| Oct 22, 2026 | BMO Capital | Michael Goldie | PT Cut | Outperform | $140→$135 |
| Oct 22, 2026 | Wells Fargo | Christian Wetherbee | PT Cut | Overweight | $160→$155 |
| Oct 22, 2026 | Argus Research | John Staszak | PT Cut | Buy | $140→$125 |
| Oct 22, 2026 | Susquehanna | Christopher Stathoulopoulos | PT Cut | Positive | $150→$130 |
| Oct 16, 2026 | UBS | Atul Maheswari | PT Cut | Buy | $146→$139 |
| Oct 7, 2026 | Susquehanna | Christopher Stathoulopoulos | PT Cut | Positive | $165→$150 |
| Oct 6, 2026 | Wells Fargo | Christian Wetherbee | PT Cut | Overweight | $165→$160 |
| Oct 2, 2026 | TD Cowen | Tom Fitzgerald | PT Cut | Buy | $192→$167 |
| Sep 28, 2026 | BMO Capital | Michael Goldie | PT Cut | Outperform | $158→$140 |
| Sep 24, 2026 | UBS | Atul Maheswari | PT Raise | Buy | $137→$146 |
| Sep 18, 2026 | Rothschild & Co | James Goodall | PT Cut | Buy | $165→$150 |
| Sep 11, 2026 | Barclays | Brandon Oglenski | PT Cut | Overweight | $175→$160 |
| Sep 10, 2026 | UBS | Atul Maheswari | PT Cut | Buy | $153→$137 |
| Aug 24, 2026 | TD Cowen | Tom Fitzgerald | PT Cut | Buy | $205→$192 |
| Jul 17, 2026 | Morgan Stanley | Ravi Shanker | PT Raise | Overweight | $185→$190 |
| Jul 17, 2026 | JP Morgan | Jamie Baker | PT Raise | Overweight | $156→$203 |
| Jul 17, 2026 | Susquehanna | Christopher Stathoulopoulos | PT Cut | Positive | $172→$165 |
| Jul 7, 2026 | Susquehanna | Christopher Stathoulopoulos | PT Raise | Positive | $135→$172 |
| Jul 6, 2026 | Morgan Stanley | Ravi Shanker | PT Raise | Overweight | $182→$185 |
| Jul 2, 2026 | BMO Capital | Michael Goldie | PT Raise | Outperform | $130→$158 |
